Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Eli Lilly and Company -

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

Related Articles

Latest in News

More from Eli Lilly and Company | Eli Lilly and Company Anti-obesity medication Weight loss Obstructive sleep apnea Obesity